You have successfully logged out.
Help prevent and treat diabetic foot ulcers
A diabetic foot syndrome (DFS) is a common complication of diabetes mellitus affecting every fourth patient with diabetes at some point in his life. The risk of developing DFS increases with time.
A consequence of DFS is the ultimate skin breakdown or foot ulceration which includes all changes in the foot as a result of diabetic polyneuropathy as well as diabetic micro- and macroangiopathic changes.
Additionally, to the diabetic foot ulcer formation a Charcot foot can develop which is another feature of DFS. Charcot foot is a deformation of the foot characterized by a disturbance of the bone metabolism due to diabetes with fractures of the bones, joint dislocations, fusion of bone fragments and others. This is called diabetic osteoarthropathy and result in very complex and variable deformations of the foot.
Though the diabetic Charcot foot can develop without foot ulcer it is often accompanied by diabetic foot ulcers because the deformations result in pressure ulcerations when standing or walking or even when wearing shoes not tailored to the specific foot anatomy.
Diabetes can impact the peripheral nervous system in many ways. Often patients have numbness, tingling, pain, and/or weakness beginning in the feet and progressively increasing the risk of foot ulcerations, e.g. by tight shoes, abrasive socks or unnoticed micro trauma to the skin. Additionally, the resistance of the skin to trauma can be impaired because the function of skin appendages, including the hair follicle and sebaceous glands is altered in diabetic neuropathy.
Another risk factor contributing to DFS is diabetic angiopathy. Larger arteries calcify (macroangiopathy) and the capillary basement membranes of smaller arteries thicken (microangiopathy), which can lead to impaired microcirculation.
Skin integrity of the foot
No open lesion; patient may have severely deformed foot.
Maintain skin integrity
The formulation of Linovera® and Linovera® Emulsion is based on hyperoxygenated fatty acids, important linoleic acids which can contribute to a healthy skin structure. Linovera® Emulsion is indicated for prevention and treatment of lower limb ulcers, diabetic foot ulcers and stage 1 pressure ulcers.
Askina® Heel is a non adhesive hydrocellular heel dressing that protects the heel area from shear stresses and reduces pressure from external forces.
A top priority in treating the diabetic foot syndrome is to avoid amputation.Because currently, the majority of all foot and lower leg amputations are performed on patients with diabetes mellitus. It is estimated that amputations occur 40 times more frequent in patients affected by diabetes compared to non-diabetic patients.
Depending on the extent of the tissue damage, diabetic foot ulcers can be categorized into five grades, with every grade requiring its specific treatment.
Superficial ulcer involving the full skin thickness but not underlying tissues
Keep the wound bed clean for granulation tissue to form
Prontosan® Wound Irrigation Solution is indicated for cleansing irrigation and moistening of acute and chronic wounds.
The use of Prontosan® Wound Gel X can provide long-lasting cleansing and decontamination of the wound bed between dressing changes.
Prontosan® Debridement Pad has been designed to support the wound bed preparation when used in conjunction with Prontosan® Wound Irrigation Solution.
Askina® Calgitrol Paste is a dressing consisting of an ionic silver alginate matrix in paste form, which provides antimicrobial barrier and helps prevent contamination from external bacteria. In the presence of wound exudate, the silver alginate matrix helps maintain a moist wound environment conducive to natural healing conditions.
Askina® DresSil Border is a self adherent foam dressing with soft silicone adhesive on one side and a vapor permeable waterproof film on the other. With its circular shaped island of foam and the additional adhesive border it is specially designed for small, deep wounds, e.g. diabetic foot ulcers.
Deep ulcer that penetrates down to the ligaments and muscles but not to the bones.
Prontosan® Wound Irrigation Solution is indicated for cleansing irrigation and moistening of acute and chronic wounds.
The use of Prontosan® Wound Gel X can provide long-lasting cleansing and decontamination of the wound bed between dressing changes.
Prontosan® Debridement Pad has been designed to support the wound bed preparation when used in conjunction with Prontosan® Wound Irrigation Solution.
Askina® Calgitrol is a range of dressings consisting of an ionic silver alginate matrix in paste form, which provides antimicrobial barrier and helps prevent contamination from external bacteria. In the presence of wound exudate, the silver alginate matrix helps maintain a moist wound environment conducive to natural healing conditions. Askina® Calgitrol is available in three different forms, Askina® Calgitrol Paste and Askina® Calgitrol Ag.
Askina® Sorb and Askina® Sorb Rope are sterile primary alginate dressings suitable for the management of moderate to heavily exuding wounds, e.g. DFU. When in contact with wound exudate, the alginate-CMC fibers are fast gelling and form a soft moist gel conducive to natural healing.
Askina® DresSil and Askina® DresSil Border help to maintain a moist wound environment conducive to natural healing conditions with a perfored silicone wound contact layer, a highly absorbent polyurethane foam and a vapor permeable waterproof outer film.
Deep ulcer with cellulitis or abscess formation, often with osteomyelitis
Prontosan® Wound Irrigation Solution is indicated for cleansing irrigation and moistening of acute and chronic wounds.
The use of Prontosan® Wound Gel X can provide long-lasting cleansing and decontamination of the wound bed between dressing changes.
Prontosan® Debridement Pad has been designed to support the wound bed preparation when used in conjunction with Prontosan® Wound Irrigation Solution.
Askina® Calgitrol is a range of primary dressing consisting of an ionic silver alginate matrix in paste form, which provides antimicrobial barrier and helps prevent contamination from external bacteria. In the presence of wound exudate, the silver alginate matrix helps maintain a moist wound environment conducive to natural healing conditions. Askina® Calgitrol is available in three different forms, Askina® Calgitrol Paste and Askina® Calgitrol Ag.
Askina® Foam is a hydrophilic foam dressing which helps to maintain a moist wound environment conducive to natural healing conditions.
Askina® Carbosorb is a conformable, sterile wound dressing combining two layers: an absorbent layer and an activated charcoal layer for the absorption of bacterial malodor.
Localized gangrene
Prontosan® Wound Irrigation Solution is indicated for cleansing irrigation and moistening of acute and chronic wounds.
The use of Prontosan® Wound Gel X can provide long-lasting cleansing and decontamination of the wound bed between dressing changes.
Prontosan® Debridement Pad has been designed to support the wound bed preparation when used in conjunction with Prontosan® Wound Irrigation Solution.
Askina® Calgitrol® is a range of primary dressing consisting of an ionic silver alginate matrix in paste form, which provides antimicrobial barrier and helps prevent contamination from external bacteria. In the presence of wound exudate, the silver alginate matrix helps maintain a moist wound environment conducive to natural healing conditions. Askina® Calgitrol is available in three different forms, Askina® Calgitrol Paste and Askina® Calgitrol® Ag.
Askina® Foam is a hydrophilic foam dressing which helps to maintain a moist wound environment conducive to natural healing conditions.
Askina® Carbosorb is a conformable, sterile wound dressing combining two layers: an absorbent layer and an activated charcoal layer for the absorption of bacterial malodor.
